Global Hyper Immune Globulin Market Research Report 2023
Hyperimmune globulin is similar to intravenous immunoglobulin (IVIG) except that it is prepared from the plasma of donors with high titers of antibody against a specific organism or antigen. Some agents against which hyperimmune globulins are available include hepatitis B, rabies, tetanus toxin, varicella-zoster, etc. Administration of hyperimmune globulin provides 'passive' immunity to the patient against an agent. This is in contrast to vaccines that provide 'active' immunity. However, vaccines take much longer to achieve that purpose while hyperimmune globulin provides instant 'passive' short-lived immunity. Hyperimmune globulin may have serious side effects, thus usage is taken very seriously.
According to QYResearch’s new survey, global Hyper Immune Globulin market is projected to reach US$ 2839.8 million in 2029, increasing from US$ 1867 million in 2022, with the CAGR of 6.2% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Hyper Immune Globulin market research.
The human plasma-based hyperimmune preparation market is driven by the increasing demand for effective treatments against specific infectious diseases and other medical conditions. Hyperimmune preparations are derived from the plasma of individuals who have recovered from a particular infection or have been vaccinated against a specific pathogen. These preparations contain high levels of antibodies targeting the specific pathogen or antigen, making them valuable for passive immunization in individuals at risk or currently affected by the same disease. The growing prevalence of infectious diseases, such as COVID-19, and the need for rapid and targeted therapeutic solutions have fueled market growth. Moreover, advancements in plasma fractionation and purification technologies have improved the production and safety of hyperimmune preparations. However, the market also faces challenges, including the complexity of large-scale plasma collection and processing, ensuring consistent antibody levels in the preparations, and maintaining a robust supply chain to meet demand during disease outbreaks or pandemics. Additionally, regulatory considerations and the need for stringent safety and quality standards are crucial challenges for manufacturers. To succeed in this market, companies must focus on research and development to expand the applications of hyperimmune preparations, collaborate with healthcare authorities and organizations to establish guidelines and protocols, and work towards enhancing plasma collection infrastructure to ensure a steady supply of human plasma-based hyperimmune preparations for critical therapeutic interventions.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Hyper Immune Globulin market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
According to QYResearch’s new survey, global Hyper Immune Globulin market is projected to reach US$ 2839.8 million in 2029, increasing from US$ 1867 million in 2022, with the CAGR of 6.2% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Hyper Immune Globulin market research.
The human plasma-based hyperimmune preparation market is driven by the increasing demand for effective treatments against specific infectious diseases and other medical conditions. Hyperimmune preparations are derived from the plasma of individuals who have recovered from a particular infection or have been vaccinated against a specific pathogen. These preparations contain high levels of antibodies targeting the specific pathogen or antigen, making them valuable for passive immunization in individuals at risk or currently affected by the same disease. The growing prevalence of infectious diseases, such as COVID-19, and the need for rapid and targeted therapeutic solutions have fueled market growth. Moreover, advancements in plasma fractionation and purification technologies have improved the production and safety of hyperimmune preparations. However, the market also faces challenges, including the complexity of large-scale plasma collection and processing, ensuring consistent antibody levels in the preparations, and maintaining a robust supply chain to meet demand during disease outbreaks or pandemics. Additionally, regulatory considerations and the need for stringent safety and quality standards are crucial challenges for manufacturers. To succeed in this market, companies must focus on research and development to expand the applications of hyperimmune preparations, collaborate with healthcare authorities and organizations to establish guidelines and protocols, and work towards enhancing plasma collection infrastructure to ensure a steady supply of human plasma-based hyperimmune preparations for critical therapeutic interventions.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Hyper Immune Globulin market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
- CSL Behring
- Grifols
- Biotest
- Kedrion
- CBPO
- Emergent (Cangene)
- Kamada
- CNBG
- Hualan Bio
- Shanghai RAAS
- Sichuan Yuanda Shuyang
- ADMA Biologics
- Hepatitis B Immunoglobulins
- Rabies Immunoglobulins
- Tetanus Immunoglobulins
- Rho(D) Immunoglobulins
- Others
- Government Institutions
- Private Sector
- Others
- North America
- United States
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
1 HYPER IMMUNE GLOBULIN MARKET OVERVIEW
1.1 Product Overview and Scope of Hyper Immune Globulin
1.2 Hyper Immune Globulin Segment by Type
1.2.1 Global Hyper Immune Globulin Market Value Comparison by Type (2023-2029)
1.2.2 Hepatitis B Immunoglobulins
1.2.3 Rabies Immunoglobulins
1.2.4 Tetanus Immunoglobulins
1.2.5 Rho(D) Immunoglobulins
1.2.6 Others
1.3 Hyper Immune Globulin Segment by Application
1.3.1 Global Hyper Immune Globulin Market Value by Application: (2023-2029)
1.3.2 Government Institutions
1.3.3 Private Sector
1.3.4 Others
1.4 Global Hyper Immune Globulin Market Size Estimates and Forecasts
1.4.1 Global Hyper Immune Globulin Revenue 2018-2029
1.4.2 Global Hyper Immune Globulin Sales 2018-2029
1.4.3 Global Hyper Immune Globulin Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 HYPER IMMUNE GLOBULIN MARKET COMPETITION BY MANUFACTURERS
2.1 Global Hyper Immune Globulin Sales Market Share by Manufacturers (2018-2023)
2.2 Global Hyper Immune Globulin Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Hyper Immune Globulin Average Price by Manufacturers (2018-2023)
2.4 Global Hyper Immune Globulin Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Hyper Immune Globulin, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Hyper Immune Globulin, Product Type & Application
2.7 Hyper Immune Globulin Market Competitive Situation and Trends
2.7.1 Hyper Immune Globulin Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Hyper Immune Globulin Players Market Share by Revenue
2.7.3 Global Hyper Immune Globulin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 HYPER IMMUNE GLOBULIN RETROSPECTIVE MARKET SCENARIO BY REGION
3.1 Global Hyper Immune Globulin Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Hyper Immune Globulin Global Hyper Immune Globulin Sales by Region: 2018-2029
3.2.1 Global Hyper Immune Globulin Sales by Region: 2018-2023
3.2.2 Global Hyper Immune Globulin Sales by Region: 2024-2029
3.3 Global Hyper Immune Globulin Global Hyper Immune Globulin Revenue by Region: 2018-2029
3.3.1 Global Hyper Immune Globulin Revenue by Region: 2018-2023
3.3.2 Global Hyper Immune Globulin Revenue by Region: 2024-2029
3.4 North America Hyper Immune Globulin Market Facts & Figures by Country
3.4.1 North America Hyper Immune Globulin Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Hyper Immune Globulin Sales by Country (2018-2029)
3.4.3 North America Hyper Immune Globulin Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Hyper Immune Globulin Market Facts & Figures by Country
3.5.1 Europe Hyper Immune Globulin Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Hyper Immune Globulin Sales by Country (2018-2029)
3.5.3 Europe Hyper Immune Globulin Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Hyper Immune Globulin Market Facts & Figures by Country
3.6.1 Asia Pacific Hyper Immune Globulin Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Hyper Immune Globulin Sales by Country (2018-2029)
3.6.3 Asia Pacific Hyper Immune Globulin Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Hyper Immune Globulin Market Facts & Figures by Country
3.7.1 Latin America Hyper Immune Globulin Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Hyper Immune Globulin Sales by Country (2018-2029)
3.7.3 Latin America Hyper Immune Globulin Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Hyper Immune Globulin Market Facts & Figures by Country
3.8.1 Middle East and Africa Hyper Immune Globulin Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Hyper Immune Globulin Sales by Country (2018-2029)
3.8.3 Middle East and Africa Hyper Immune Globulin Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 SEGMENT BY TYPE
4.1 Global Hyper Immune Globulin Sales by Type (2018-2029)
4.1.1 Global Hyper Immune Globulin Sales by Type (2018-2023)
4.1.2 Global Hyper Immune Globulin Sales by Type (2024-2029)
4.1.3 Global Hyper Immune Globulin Sales Market Share by Type (2018-2029)
4.2 Global Hyper Immune Globulin Revenue by Type (2018-2029)
4.2.1 Global Hyper Immune Globulin Revenue by Type (2018-2023)
4.2.2 Global Hyper Immune Globulin Revenue by Type (2024-2029)
4.2.3 Global Hyper Immune Globulin Revenue Market Share by Type (2018-2029)
4.3 Global Hyper Immune Globulin Price by Type (2018-2029)
5 SEGMENT BY APPLICATION
5.1 Global Hyper Immune Globulin Sales by Application (2018-2029)
5.1.1 Global Hyper Immune Globulin Sales by Application (2018-2023)
5.1.2 Global Hyper Immune Globulin Sales by Application (2024-2029)
5.1.3 Global Hyper Immune Globulin Sales Market Share by Application (2018-2029)
5.2 Global Hyper Immune Globulin Revenue by Application (2018-2029)
5.2.1 Global Hyper Immune Globulin Revenue by Application (2018-2023)
5.2.2 Global Hyper Immune Globulin Revenue by Application (2024-2029)
5.2.3 Global Hyper Immune Globulin Revenue Market Share by Application (2018-2029)
5.3 Global Hyper Immune Globulin Price by Application (2018-2029)
6 KEY COMPANIES PROFILED
6.1 CSL Behring
6.1.1 CSL Behring Corporation Information
6.1.2 CSL Behring Description and Business Overview
6.1.3 CSL Behring Hyper Immune Globulin Sales, Revenue and Gross Margin (2018-2023)
6.1.4 CSL Behring Hyper Immune Globulin Product Portfolio
6.1.5 CSL Behring Recent Developments/Updates
6.2 Grifols
6.2.1 Grifols Corporation Information
6.2.2 Grifols Description and Business Overview
6.2.3 Grifols Hyper Immune Globulin Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Grifols Hyper Immune Globulin Product Portfolio
6.2.5 Grifols Recent Developments/Updates
6.3 Biotest
6.3.1 Biotest Corporation Information
6.3.2 Biotest Description and Business Overview
6.3.3 Biotest Hyper Immune Globulin Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Biotest Hyper Immune Globulin Product Portfolio
6.3.5 Biotest Recent Developments/Updates
6.4 Kedrion
6.4.1 Kedrion Corporation Information
6.4.2 Kedrion Description and Business Overview
6.4.3 Kedrion Hyper Immune Globulin Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Kedrion Hyper Immune Globulin Product Portfolio
6.4.5 Kedrion Recent Developments/Updates
6.5 CBPO
6.5.1 CBPO Corporation Information
6.5.2 CBPO Description and Business Overview
6.5.3 CBPO Hyper Immune Globulin Sales, Revenue and Gross Margin (2018-2023)
6.5.4 CBPO Hyper Immune Globulin Product Portfolio
6.5.5 CBPO Recent Developments/Updates
6.6 Emergent (Cangene)
6.6.1 Emergent (Cangene) Corporation Information
6.6.2 Emergent (Cangene) Description and Business Overview
6.6.3 Emergent (Cangene) Hyper Immune Globulin Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Emergent (Cangene) Hyper Immune Globulin Product Portfolio
6.6.5 Emergent (Cangene) Recent Developments/Updates
6.7 Kamada
6.6.1 Kamada Corporation Information
6.6.2 Kamada Description and Business Overview
6.6.3 Kamada Hyper Immune Globulin Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Kamada Hyper Immune Globulin Product Portfolio
6.7.5 Kamada Recent Developments/Updates
6.8 CNBG
6.8.1 CNBG Corporation Information
6.8.2 CNBG Description and Business Overview
6.8.3 CNBG Hyper Immune Globulin Sales, Revenue and Gross Margin (2018-2023)
6.8.4 CNBG Hyper Immune Globulin Product Portfolio
6.8.5 CNBG Recent Developments/Updates
6.9 Hualan Bio
6.9.1 Hualan Bio Corporation Information
6.9.2 Hualan Bio Description and Business Overview
6.9.3 Hualan Bio Hyper Immune Globulin Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Hualan Bio Hyper Immune Globulin Product Portfolio
6.9.5 Hualan Bio Recent Developments/Updates
6.10 Shanghai RAAS
6.10.1 Shanghai RAAS Corporation Information
6.10.2 Shanghai RAAS Description and Business Overview
6.10.3 Shanghai RAAS Hyper Immune Globulin Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Shanghai RAAS Hyper Immune Globulin Product Portfolio
6.10.5 Shanghai RAAS Recent Developments/Updates
6.11 Sichuan Yuanda Shuyang
6.11.1 Sichuan Yuanda Shuyang Corporation Information
6.11.2 Sichuan Yuanda Shuyang Hyper Immune Globulin Description and Business Overview
6.11.3 Sichuan Yuanda Shuyang Hyper Immune Globulin Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Sichuan Yuanda Shuyang Hyper Immune Globulin Product Portfolio
6.11.5 Sichuan Yuanda Shuyang Recent Developments/Updates
6.12 ADMA Biologics
6.12.1 ADMA Biologics Corporation Information
6.12.2 ADMA Biologics Hyper Immune Globulin Description and Business Overview
6.12.3 ADMA Biologics Hyper Immune Globulin Sales, Revenue and Gross Margin (2018-2023)
6.12.4 ADMA Biologics Hyper Immune Globulin Product Portfolio
6.12.5 ADMA Biologics Recent Developments/Updates
7 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
7.1 Hyper Immune Globulin Industry Chain Analysis
7.2 Hyper Immune Globulin Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Hyper Immune Globulin Production Mode & Process
7.4 Hyper Immune Globulin Sales and Marketing
7.4.1 Hyper Immune Globulin Sales Channels
7.4.2 Hyper Immune Globulin Distributors
7.5 Hyper Immune Globulin Customers
8 HYPER IMMUNE GLOBULIN MARKET DYNAMICS
8.1 Hyper Immune Globulin Industry Trends
8.2 Hyper Immune Globulin Market Drivers
8.3 Hyper Immune Globulin Market Challenges
8.4 Hyper Immune Globulin Market Restraints
9 RESEARCH FINDING AND CONCLUSION
10 METHODOLOGY AND DATA SOURCE
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Overview and Scope of Hyper Immune Globulin
1.2 Hyper Immune Globulin Segment by Type
1.2.1 Global Hyper Immune Globulin Market Value Comparison by Type (2023-2029)
1.2.2 Hepatitis B Immunoglobulins
1.2.3 Rabies Immunoglobulins
1.2.4 Tetanus Immunoglobulins
1.2.5 Rho(D) Immunoglobulins
1.2.6 Others
1.3 Hyper Immune Globulin Segment by Application
1.3.1 Global Hyper Immune Globulin Market Value by Application: (2023-2029)
1.3.2 Government Institutions
1.3.3 Private Sector
1.3.4 Others
1.4 Global Hyper Immune Globulin Market Size Estimates and Forecasts
1.4.1 Global Hyper Immune Globulin Revenue 2018-2029
1.4.2 Global Hyper Immune Globulin Sales 2018-2029
1.4.3 Global Hyper Immune Globulin Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 HYPER IMMUNE GLOBULIN MARKET COMPETITION BY MANUFACTURERS
2.1 Global Hyper Immune Globulin Sales Market Share by Manufacturers (2018-2023)
2.2 Global Hyper Immune Globulin Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Hyper Immune Globulin Average Price by Manufacturers (2018-2023)
2.4 Global Hyper Immune Globulin Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Hyper Immune Globulin, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Hyper Immune Globulin, Product Type & Application
2.7 Hyper Immune Globulin Market Competitive Situation and Trends
2.7.1 Hyper Immune Globulin Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Hyper Immune Globulin Players Market Share by Revenue
2.7.3 Global Hyper Immune Globulin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 HYPER IMMUNE GLOBULIN RETROSPECTIVE MARKET SCENARIO BY REGION
3.1 Global Hyper Immune Globulin Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Hyper Immune Globulin Global Hyper Immune Globulin Sales by Region: 2018-2029
3.2.1 Global Hyper Immune Globulin Sales by Region: 2018-2023
3.2.2 Global Hyper Immune Globulin Sales by Region: 2024-2029
3.3 Global Hyper Immune Globulin Global Hyper Immune Globulin Revenue by Region: 2018-2029
3.3.1 Global Hyper Immune Globulin Revenue by Region: 2018-2023
3.3.2 Global Hyper Immune Globulin Revenue by Region: 2024-2029
3.4 North America Hyper Immune Globulin Market Facts & Figures by Country
3.4.1 North America Hyper Immune Globulin Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Hyper Immune Globulin Sales by Country (2018-2029)
3.4.3 North America Hyper Immune Globulin Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Hyper Immune Globulin Market Facts & Figures by Country
3.5.1 Europe Hyper Immune Globulin Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Hyper Immune Globulin Sales by Country (2018-2029)
3.5.3 Europe Hyper Immune Globulin Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Hyper Immune Globulin Market Facts & Figures by Country
3.6.1 Asia Pacific Hyper Immune Globulin Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Hyper Immune Globulin Sales by Country (2018-2029)
3.6.3 Asia Pacific Hyper Immune Globulin Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Hyper Immune Globulin Market Facts & Figures by Country
3.7.1 Latin America Hyper Immune Globulin Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Hyper Immune Globulin Sales by Country (2018-2029)
3.7.3 Latin America Hyper Immune Globulin Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Hyper Immune Globulin Market Facts & Figures by Country
3.8.1 Middle East and Africa Hyper Immune Globulin Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Hyper Immune Globulin Sales by Country (2018-2029)
3.8.3 Middle East and Africa Hyper Immune Globulin Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 SEGMENT BY TYPE
4.1 Global Hyper Immune Globulin Sales by Type (2018-2029)
4.1.1 Global Hyper Immune Globulin Sales by Type (2018-2023)
4.1.2 Global Hyper Immune Globulin Sales by Type (2024-2029)
4.1.3 Global Hyper Immune Globulin Sales Market Share by Type (2018-2029)
4.2 Global Hyper Immune Globulin Revenue by Type (2018-2029)
4.2.1 Global Hyper Immune Globulin Revenue by Type (2018-2023)
4.2.2 Global Hyper Immune Globulin Revenue by Type (2024-2029)
4.2.3 Global Hyper Immune Globulin Revenue Market Share by Type (2018-2029)
4.3 Global Hyper Immune Globulin Price by Type (2018-2029)
5 SEGMENT BY APPLICATION
5.1 Global Hyper Immune Globulin Sales by Application (2018-2029)
5.1.1 Global Hyper Immune Globulin Sales by Application (2018-2023)
5.1.2 Global Hyper Immune Globulin Sales by Application (2024-2029)
5.1.3 Global Hyper Immune Globulin Sales Market Share by Application (2018-2029)
5.2 Global Hyper Immune Globulin Revenue by Application (2018-2029)
5.2.1 Global Hyper Immune Globulin Revenue by Application (2018-2023)
5.2.2 Global Hyper Immune Globulin Revenue by Application (2024-2029)
5.2.3 Global Hyper Immune Globulin Revenue Market Share by Application (2018-2029)
5.3 Global Hyper Immune Globulin Price by Application (2018-2029)
6 KEY COMPANIES PROFILED
6.1 CSL Behring
6.1.1 CSL Behring Corporation Information
6.1.2 CSL Behring Description and Business Overview
6.1.3 CSL Behring Hyper Immune Globulin Sales, Revenue and Gross Margin (2018-2023)
6.1.4 CSL Behring Hyper Immune Globulin Product Portfolio
6.1.5 CSL Behring Recent Developments/Updates
6.2 Grifols
6.2.1 Grifols Corporation Information
6.2.2 Grifols Description and Business Overview
6.2.3 Grifols Hyper Immune Globulin Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Grifols Hyper Immune Globulin Product Portfolio
6.2.5 Grifols Recent Developments/Updates
6.3 Biotest
6.3.1 Biotest Corporation Information
6.3.2 Biotest Description and Business Overview
6.3.3 Biotest Hyper Immune Globulin Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Biotest Hyper Immune Globulin Product Portfolio
6.3.5 Biotest Recent Developments/Updates
6.4 Kedrion
6.4.1 Kedrion Corporation Information
6.4.2 Kedrion Description and Business Overview
6.4.3 Kedrion Hyper Immune Globulin Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Kedrion Hyper Immune Globulin Product Portfolio
6.4.5 Kedrion Recent Developments/Updates
6.5 CBPO
6.5.1 CBPO Corporation Information
6.5.2 CBPO Description and Business Overview
6.5.3 CBPO Hyper Immune Globulin Sales, Revenue and Gross Margin (2018-2023)
6.5.4 CBPO Hyper Immune Globulin Product Portfolio
6.5.5 CBPO Recent Developments/Updates
6.6 Emergent (Cangene)
6.6.1 Emergent (Cangene) Corporation Information
6.6.2 Emergent (Cangene) Description and Business Overview
6.6.3 Emergent (Cangene) Hyper Immune Globulin Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Emergent (Cangene) Hyper Immune Globulin Product Portfolio
6.6.5 Emergent (Cangene) Recent Developments/Updates
6.7 Kamada
6.6.1 Kamada Corporation Information
6.6.2 Kamada Description and Business Overview
6.6.3 Kamada Hyper Immune Globulin Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Kamada Hyper Immune Globulin Product Portfolio
6.7.5 Kamada Recent Developments/Updates
6.8 CNBG
6.8.1 CNBG Corporation Information
6.8.2 CNBG Description and Business Overview
6.8.3 CNBG Hyper Immune Globulin Sales, Revenue and Gross Margin (2018-2023)
6.8.4 CNBG Hyper Immune Globulin Product Portfolio
6.8.5 CNBG Recent Developments/Updates
6.9 Hualan Bio
6.9.1 Hualan Bio Corporation Information
6.9.2 Hualan Bio Description and Business Overview
6.9.3 Hualan Bio Hyper Immune Globulin Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Hualan Bio Hyper Immune Globulin Product Portfolio
6.9.5 Hualan Bio Recent Developments/Updates
6.10 Shanghai RAAS
6.10.1 Shanghai RAAS Corporation Information
6.10.2 Shanghai RAAS Description and Business Overview
6.10.3 Shanghai RAAS Hyper Immune Globulin Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Shanghai RAAS Hyper Immune Globulin Product Portfolio
6.10.5 Shanghai RAAS Recent Developments/Updates
6.11 Sichuan Yuanda Shuyang
6.11.1 Sichuan Yuanda Shuyang Corporation Information
6.11.2 Sichuan Yuanda Shuyang Hyper Immune Globulin Description and Business Overview
6.11.3 Sichuan Yuanda Shuyang Hyper Immune Globulin Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Sichuan Yuanda Shuyang Hyper Immune Globulin Product Portfolio
6.11.5 Sichuan Yuanda Shuyang Recent Developments/Updates
6.12 ADMA Biologics
6.12.1 ADMA Biologics Corporation Information
6.12.2 ADMA Biologics Hyper Immune Globulin Description and Business Overview
6.12.3 ADMA Biologics Hyper Immune Globulin Sales, Revenue and Gross Margin (2018-2023)
6.12.4 ADMA Biologics Hyper Immune Globulin Product Portfolio
6.12.5 ADMA Biologics Recent Developments/Updates
7 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
7.1 Hyper Immune Globulin Industry Chain Analysis
7.2 Hyper Immune Globulin Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Hyper Immune Globulin Production Mode & Process
7.4 Hyper Immune Globulin Sales and Marketing
7.4.1 Hyper Immune Globulin Sales Channels
7.4.2 Hyper Immune Globulin Distributors
7.5 Hyper Immune Globulin Customers
8 HYPER IMMUNE GLOBULIN MARKET DYNAMICS
8.1 Hyper Immune Globulin Industry Trends
8.2 Hyper Immune Globulin Market Drivers
8.3 Hyper Immune Globulin Market Challenges
8.4 Hyper Immune Globulin Market Restraints
9 RESEARCH FINDING AND CONCLUSION
10 METHODOLOGY AND DATA SOURCE
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
LIST OF TABLES
Table 1. Global Hyper Immune Globulin Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Hyper Immune Globulin Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Hyper Immune Globulin Market Competitive Situation by Manufacturers in 2022
Table 4. Global Hyper Immune Globulin Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Hyper Immune Globulin Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Hyper Immune Globulin Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Hyper Immune Globulin Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Hyper Immune Globulin Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Hyper Immune Globulin, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Hyper Immune Globulin, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Hyper Immune Globulin, Product Type & Application
Table 12. Global Key Manufacturers of Hyper Immune Globulin, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Hyper Immune Globulin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hyper Immune Globulin as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Hyper Immune Globulin Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Hyper Immune Globulin Sales by Region (2018-2023) & (K Units)
Table 18. Global Hyper Immune Globulin Sales Market Share by Region (2018-2023)
Table 19. Global Hyper Immune Globulin Sales by Region (2024-2029) & (K Units)
Table 20. Global Hyper Immune Globulin Sales Market Share by Region (2024-2029)
Table 21. Global Hyper Immune Globulin Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Hyper Immune Globulin Revenue Market Share by Region (2018-2023)
Table 23. Global Hyper Immune Globulin Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Hyper Immune Globulin Revenue Market Share by Region (2024-2029)
Table 25. North America Hyper Immune Globulin Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Hyper Immune Globulin Sales by Country (2018-2023) & (K Units)
Table 27. North America Hyper Immune Globulin Sales by Country (2024-2029) & (K Units)
Table 28. North America Hyper Immune Globulin Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Hyper Immune Globulin Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Hyper Immune Globulin Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Hyper Immune Globulin Sales by Country (2018-2023) & (K Units)
Table 32. Europe Hyper Immune Globulin Sales by Country (2024-2029) & (K Units)
Table 33. Europe Hyper Immune Globulin Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Hyper Immune Globulin Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Hyper Immune Globulin Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Hyper Immune Globulin Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Hyper Immune Globulin Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Hyper Immune Globulin Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Hyper Immune Globulin Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Hyper Immune Globulin Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Hyper Immune Globulin Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Hyper Immune Globulin Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Hyper Immune Globulin Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Hyper Immune Globulin Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Hyper Immune Globulin Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Hyper Immune Globulin Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Hyper Immune Globulin Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Hyper Immune Globulin Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Hyper Immune Globulin Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Hyper Immune Globulin Sales (K Units) by Type (2018-2023)
Table 51. Global Hyper Immune Globulin Sales (K Units) by Type (2024-2029)
Table 52. Global Hyper Immune Globulin Sales Market Share by Type (2018-2023)
Table 53. Global Hyper Immune Globulin Sales Market Share by Type (2024-2029)
Table 54. Global Hyper Immune Globulin Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Hyper Immune Globulin Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Hyper Immune Globulin Revenue Market Share by Type (2018-2023)
Table 57. Global Hyper Immune Globulin Revenue Market Share by Type (2024-2029)
Table 58. Global Hyper Immune Globulin Price (US$/Unit) by Type (2018-2023)
Table 59. Global Hyper Immune Globulin Price (US$/Unit) by Type (2024-2029)
Table 60. Global Hyper Immune Globulin Sales (K Units) by Application (2018-2023)
Table 61. Global Hyper Immune Globulin Sales (K Units) by Application (2024-2029)
Table 62. Global Hyper Immune Globulin Sales Market Share by Application (2018-2023)
Table 63. Global Hyper Immune Globulin Sales Market Share by Application (2024-2029)
Table 64. Global Hyper Immune Globulin Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Hyper Immune Globulin Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Hyper Immune Globulin Revenue Market Share by Application (2018-2023)
Table 67. Global Hyper Immune Globulin Revenue Market Share by Application (2024-2029)
Table 68. Global Hyper Immune Globulin Price (US$/Unit) by Application (2018-2023)
Table 69. Global Hyper Immune Globulin Price (US$/Unit) by Application (2024-2029)
Table 70. CSL Behring Corporation Information
Table 71. CSL Behring Description and Business Overview
Table 72. CSL Behring Hyper Immune Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. CSL Behring Hyper Immune Globulin Product
Table 74. CSL Behring Recent Developments/Updates
Table 75. Grifols Corporation Information
Table 76. Grifols Description and Business Overview
Table 77. Grifols Hyper Immune Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. Grifols Hyper Immune Globulin Product
Table 79. Grifols Recent Developments/Updates
Table 80. Biotest Corporation Information
Table 81. Biotest Description and Business Overview
Table 82. Biotest Hyper Immune Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Biotest Hyper Immune Globulin Product
Table 84. Biotest Recent Developments/Updates
Table 85. Kedrion Corporation Information
Table 86. Kedrion Description and Business Overview
Table 87. Kedrion Hyper Immune Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Kedrion Hyper Immune Globulin Product
Table 89. Kedrion Recent Developments/Updates
Table 90. CBPO Corporation Information
Table 91. CBPO Description and Business Overview
Table 92. CBPO Hyper Immune Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. CBPO Hyper Immune Globulin Product
Table 94. CBPO Recent Developments/Updates
Table 95. Emergent (Cangene) Corporation Information
Table 96. Emergent (Cangene) Description and Business Overview
Table 97. Emergent (Cangene) Hyper Immune Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Emergent (Cangene) Hyper Immune Globulin Product
Table 99. Emergent (Cangene) Recent Developments/Updates
Table 100. Kamada Corporation Information
Table 101. Kamada Description and Business Overview
Table 102. Kamada Hyper Immune Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Kamada Hyper Immune Globulin Product
Table 104. Kamada Recent Developments/Updates
Table 105. CNBG Corporation Information
Table 106. CNBG Description and Business Overview
Table 107. CNBG Hyper Immune Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. CNBG Hyper Immune Globulin Product
Table 109. CNBG Recent Developments/Updates
Table 110. Hualan Bio Corporation Information
Table 111. Hualan Bio Description and Business Overview
Table 112. Hualan Bio Hyper Immune Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Hualan Bio Hyper Immune Globulin Product
Table 114. Hualan Bio Recent Developments/Updates
Table 115. Shanghai RAAS Corporation Information
Table 116. Shanghai RAAS Description and Business Overview
Table 117. Shanghai RAAS Hyper Immune Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Shanghai RAAS Hyper Immune Globulin Product
Table 119. Shanghai RAAS Recent Developments/Updates
Table 120. Sichuan Yuanda Shuyang Corporation Information
Table 121. Sichuan Yuanda Shuyang Description and Business Overview
Table 122. Sichuan Yuanda Shuyang Hyper Immune Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. Sichuan Yuanda Shuyang Hyper Immune Globulin Product
Table 124. Sichuan Yuanda Shuyang Recent Developments/Updates
Table 125. ADMA Biologics Corporation Information
Table 126. ADMA Biologics Description and Business Overview
Table 127. ADMA Biologics Hyper Immune Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. ADMA Biologics Hyper Immune Globulin Product
Table 129. ADMA Biologics Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Hyper Immune Globulin Distributors List
Table 133. Hyper Immune Globulin Customers List
Table 134. Hyper Immune Globulin Market Trends
Table 135. Hyper Immune Globulin Market Drivers
Table 136. Hyper Immune Globulin Market Challenges
Table 137. Hyper Immune Globulin Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
Table 1. Global Hyper Immune Globulin Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Hyper Immune Globulin Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Hyper Immune Globulin Market Competitive Situation by Manufacturers in 2022
Table 4. Global Hyper Immune Globulin Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Hyper Immune Globulin Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Hyper Immune Globulin Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Hyper Immune Globulin Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Hyper Immune Globulin Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Hyper Immune Globulin, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Hyper Immune Globulin, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Hyper Immune Globulin, Product Type & Application
Table 12. Global Key Manufacturers of Hyper Immune Globulin, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Hyper Immune Globulin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hyper Immune Globulin as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Hyper Immune Globulin Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Hyper Immune Globulin Sales by Region (2018-2023) & (K Units)
Table 18. Global Hyper Immune Globulin Sales Market Share by Region (2018-2023)
Table 19. Global Hyper Immune Globulin Sales by Region (2024-2029) & (K Units)
Table 20. Global Hyper Immune Globulin Sales Market Share by Region (2024-2029)
Table 21. Global Hyper Immune Globulin Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Hyper Immune Globulin Revenue Market Share by Region (2018-2023)
Table 23. Global Hyper Immune Globulin Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Hyper Immune Globulin Revenue Market Share by Region (2024-2029)
Table 25. North America Hyper Immune Globulin Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Hyper Immune Globulin Sales by Country (2018-2023) & (K Units)
Table 27. North America Hyper Immune Globulin Sales by Country (2024-2029) & (K Units)
Table 28. North America Hyper Immune Globulin Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Hyper Immune Globulin Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Hyper Immune Globulin Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Hyper Immune Globulin Sales by Country (2018-2023) & (K Units)
Table 32. Europe Hyper Immune Globulin Sales by Country (2024-2029) & (K Units)
Table 33. Europe Hyper Immune Globulin Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Hyper Immune Globulin Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Hyper Immune Globulin Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Hyper Immune Globulin Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Hyper Immune Globulin Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Hyper Immune Globulin Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Hyper Immune Globulin Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Hyper Immune Globulin Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Hyper Immune Globulin Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Hyper Immune Globulin Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Hyper Immune Globulin Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Hyper Immune Globulin Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Hyper Immune Globulin Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Hyper Immune Globulin Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Hyper Immune Globulin Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Hyper Immune Globulin Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Hyper Immune Globulin Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Hyper Immune Globulin Sales (K Units) by Type (2018-2023)
Table 51. Global Hyper Immune Globulin Sales (K Units) by Type (2024-2029)
Table 52. Global Hyper Immune Globulin Sales Market Share by Type (2018-2023)
Table 53. Global Hyper Immune Globulin Sales Market Share by Type (2024-2029)
Table 54. Global Hyper Immune Globulin Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Hyper Immune Globulin Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Hyper Immune Globulin Revenue Market Share by Type (2018-2023)
Table 57. Global Hyper Immune Globulin Revenue Market Share by Type (2024-2029)
Table 58. Global Hyper Immune Globulin Price (US$/Unit) by Type (2018-2023)
Table 59. Global Hyper Immune Globulin Price (US$/Unit) by Type (2024-2029)
Table 60. Global Hyper Immune Globulin Sales (K Units) by Application (2018-2023)
Table 61. Global Hyper Immune Globulin Sales (K Units) by Application (2024-2029)
Table 62. Global Hyper Immune Globulin Sales Market Share by Application (2018-2023)
Table 63. Global Hyper Immune Globulin Sales Market Share by Application (2024-2029)
Table 64. Global Hyper Immune Globulin Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Hyper Immune Globulin Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Hyper Immune Globulin Revenue Market Share by Application (2018-2023)
Table 67. Global Hyper Immune Globulin Revenue Market Share by Application (2024-2029)
Table 68. Global Hyper Immune Globulin Price (US$/Unit) by Application (2018-2023)
Table 69. Global Hyper Immune Globulin Price (US$/Unit) by Application (2024-2029)
Table 70. CSL Behring Corporation Information
Table 71. CSL Behring Description and Business Overview
Table 72. CSL Behring Hyper Immune Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. CSL Behring Hyper Immune Globulin Product
Table 74. CSL Behring Recent Developments/Updates
Table 75. Grifols Corporation Information
Table 76. Grifols Description and Business Overview
Table 77. Grifols Hyper Immune Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. Grifols Hyper Immune Globulin Product
Table 79. Grifols Recent Developments/Updates
Table 80. Biotest Corporation Information
Table 81. Biotest Description and Business Overview
Table 82. Biotest Hyper Immune Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Biotest Hyper Immune Globulin Product
Table 84. Biotest Recent Developments/Updates
Table 85. Kedrion Corporation Information
Table 86. Kedrion Description and Business Overview
Table 87. Kedrion Hyper Immune Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Kedrion Hyper Immune Globulin Product
Table 89. Kedrion Recent Developments/Updates
Table 90. CBPO Corporation Information
Table 91. CBPO Description and Business Overview
Table 92. CBPO Hyper Immune Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. CBPO Hyper Immune Globulin Product
Table 94. CBPO Recent Developments/Updates
Table 95. Emergent (Cangene) Corporation Information
Table 96. Emergent (Cangene) Description and Business Overview
Table 97. Emergent (Cangene) Hyper Immune Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Emergent (Cangene) Hyper Immune Globulin Product
Table 99. Emergent (Cangene) Recent Developments/Updates
Table 100. Kamada Corporation Information
Table 101. Kamada Description and Business Overview
Table 102. Kamada Hyper Immune Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Kamada Hyper Immune Globulin Product
Table 104. Kamada Recent Developments/Updates
Table 105. CNBG Corporation Information
Table 106. CNBG Description and Business Overview
Table 107. CNBG Hyper Immune Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. CNBG Hyper Immune Globulin Product
Table 109. CNBG Recent Developments/Updates
Table 110. Hualan Bio Corporation Information
Table 111. Hualan Bio Description and Business Overview
Table 112. Hualan Bio Hyper Immune Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Hualan Bio Hyper Immune Globulin Product
Table 114. Hualan Bio Recent Developments/Updates
Table 115. Shanghai RAAS Corporation Information
Table 116. Shanghai RAAS Description and Business Overview
Table 117. Shanghai RAAS Hyper Immune Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Shanghai RAAS Hyper Immune Globulin Product
Table 119. Shanghai RAAS Recent Developments/Updates
Table 120. Sichuan Yuanda Shuyang Corporation Information
Table 121. Sichuan Yuanda Shuyang Description and Business Overview
Table 122. Sichuan Yuanda Shuyang Hyper Immune Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. Sichuan Yuanda Shuyang Hyper Immune Globulin Product
Table 124. Sichuan Yuanda Shuyang Recent Developments/Updates
Table 125. ADMA Biologics Corporation Information
Table 126. ADMA Biologics Description and Business Overview
Table 127. ADMA Biologics Hyper Immune Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. ADMA Biologics Hyper Immune Globulin Product
Table 129. ADMA Biologics Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Hyper Immune Globulin Distributors List
Table 133. Hyper Immune Globulin Customers List
Table 134. Hyper Immune Globulin Market Trends
Table 135. Hyper Immune Globulin Market Drivers
Table 136. Hyper Immune Globulin Market Challenges
Table 137. Hyper Immune Globulin Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Product Picture of Hyper Immune Globulin
Figure 2. Global Hyper Immune Globulin Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Hyper Immune Globulin Market Share by Type in 2022 & 2029
Figure 4. Hepatitis B Immunoglobulins Product Picture
Figure 5. Rabies Immunoglobulins Product Picture
Figure 6. Tetanus Immunoglobulins Product Picture
Figure 7. Rho(D) Immunoglobulins Product Picture
Figure 8. Others Product Picture
Figure 9. Global Hyper Immune Globulin Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 10. Global Hyper Immune Globulin Market Share by Application in 2022 & 2029
Figure 11. Government Institutions
Figure 12. Private Sector
Figure 13. Others
Figure 14. Global Hyper Immune Globulin Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Hyper Immune Globulin Market Size (2018-2029) & (US$ Million)
Figure 16. Global Hyper Immune Globulin Sales (2018-2029) & (K Units)
Figure 17. Global Hyper Immune Globulin Average Price (US$/Unit) & (2018-2029)
Figure 18. Hyper Immune Globulin Report Years Considered
Figure 19. Hyper Immune Globulin Sales Share by Manufacturers in 2022
Figure 20. Global Hyper Immune Globulin Revenue Share by Manufacturers in 2022
Figure 21. The Global 5 and 10 Largest Hyper Immune Globulin Players: Market Share by Revenue in 2022
Figure 22. Hyper Immune Globulin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 23. Global Hyper Immune Globulin Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 24. North America Hyper Immune Globulin Sales Market Share by Country (2018-2029)
Figure 25. North America Hyper Immune Globulin Revenue Market Share by Country (2018-2029)
Figure 26. United States Hyper Immune Globulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. Canada Hyper Immune Globulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. Europe Hyper Immune Globulin Sales Market Share by Country (2018-2029)
Figure 29. Europe Hyper Immune Globulin Revenue Market Share by Country (2018-2029)
Figure 30. Germany Hyper Immune Globulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. France Hyper Immune Globulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. U.K. Hyper Immune Globulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Italy Hyper Immune Globulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Russia Hyper Immune Globulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Asia Pacific Hyper Immune Globulin Sales Market Share by Region (2018-2029)
Figure 36. Asia Pacific Hyper Immune Globulin Revenue Market Share by Region (2018-2029)
Figure 37. China Hyper Immune Globulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Japan Hyper Immune Globulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. South Korea Hyper Immune Globulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. India Hyper Immune Globulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Australia Hyper Immune Globulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. China Taiwan Hyper Immune Globulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Indonesia Hyper Immune Globulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Thailand Hyper Immune Globulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Malaysia Hyper Immune Globulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Latin America Hyper Immune Globulin Sales Market Share by Country (2018-2029)
Figure 47. Latin America Hyper Immune Globulin Revenue Market Share by Country (2018-2029)
Figure 48. Mexico Hyper Immune Globulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Brazil Hyper Immune Globulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Argentina Hyper Immune Globulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Middle East & Africa Hyper Immune Globulin Sales Market Share by Country (2018-2029)
Figure 52. Middle East & Africa Hyper Immune Globulin Revenue Market Share by Country (2018-2029)
Figure 53. Turkey Hyper Immune Globulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Saudi Arabia Hyper Immune Globulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 55. UAE Hyper Immune Globulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 56. Global Sales Market Share of Hyper Immune Globulin by Type (2018-2029)
Figure 57. Global Revenue Market Share of Hyper Immune Globulin by Type (2018-2029)
Figure 58. Global Hyper Immune Globulin Price (US$/Unit) by Type (2018-2029)
Figure 59. Global Sales Market Share of Hyper Immune Globulin by Application (2018-2029)
Figure 60. Global Revenue Market Share of Hyper Immune Globulin by Application (2018-2029)
Figure 61. Global Hyper Immune Globulin Price (US$/Unit) by Application (2018-2029)
Figure 62. Hyper Immune Globulin Value Chain
Figure 63. Hyper Immune Globulin Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Distributors Profiles
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Figure 1. Product Picture of Hyper Immune Globulin
Figure 2. Global Hyper Immune Globulin Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Hyper Immune Globulin Market Share by Type in 2022 & 2029
Figure 4. Hepatitis B Immunoglobulins Product Picture
Figure 5. Rabies Immunoglobulins Product Picture
Figure 6. Tetanus Immunoglobulins Product Picture
Figure 7. Rho(D) Immunoglobulins Product Picture
Figure 8. Others Product Picture
Figure 9. Global Hyper Immune Globulin Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 10. Global Hyper Immune Globulin Market Share by Application in 2022 & 2029
Figure 11. Government Institutions
Figure 12. Private Sector
Figure 13. Others
Figure 14. Global Hyper Immune Globulin Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Hyper Immune Globulin Market Size (2018-2029) & (US$ Million)
Figure 16. Global Hyper Immune Globulin Sales (2018-2029) & (K Units)
Figure 17. Global Hyper Immune Globulin Average Price (US$/Unit) & (2018-2029)
Figure 18. Hyper Immune Globulin Report Years Considered
Figure 19. Hyper Immune Globulin Sales Share by Manufacturers in 2022
Figure 20. Global Hyper Immune Globulin Revenue Share by Manufacturers in 2022
Figure 21. The Global 5 and 10 Largest Hyper Immune Globulin Players: Market Share by Revenue in 2022
Figure 22. Hyper Immune Globulin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 23. Global Hyper Immune Globulin Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 24. North America Hyper Immune Globulin Sales Market Share by Country (2018-2029)
Figure 25. North America Hyper Immune Globulin Revenue Market Share by Country (2018-2029)
Figure 26. United States Hyper Immune Globulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. Canada Hyper Immune Globulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. Europe Hyper Immune Globulin Sales Market Share by Country (2018-2029)
Figure 29. Europe Hyper Immune Globulin Revenue Market Share by Country (2018-2029)
Figure 30. Germany Hyper Immune Globulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. France Hyper Immune Globulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. U.K. Hyper Immune Globulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Italy Hyper Immune Globulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Russia Hyper Immune Globulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Asia Pacific Hyper Immune Globulin Sales Market Share by Region (2018-2029)
Figure 36. Asia Pacific Hyper Immune Globulin Revenue Market Share by Region (2018-2029)
Figure 37. China Hyper Immune Globulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Japan Hyper Immune Globulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. South Korea Hyper Immune Globulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. India Hyper Immune Globulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Australia Hyper Immune Globulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. China Taiwan Hyper Immune Globulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Indonesia Hyper Immune Globulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Thailand Hyper Immune Globulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Malaysia Hyper Immune Globulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Latin America Hyper Immune Globulin Sales Market Share by Country (2018-2029)
Figure 47. Latin America Hyper Immune Globulin Revenue Market Share by Country (2018-2029)
Figure 48. Mexico Hyper Immune Globulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Brazil Hyper Immune Globulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Argentina Hyper Immune Globulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Middle East & Africa Hyper Immune Globulin Sales Market Share by Country (2018-2029)
Figure 52. Middle East & Africa Hyper Immune Globulin Revenue Market Share by Country (2018-2029)
Figure 53. Turkey Hyper Immune Globulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Saudi Arabia Hyper Immune Globulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 55. UAE Hyper Immune Globulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 56. Global Sales Market Share of Hyper Immune Globulin by Type (2018-2029)
Figure 57. Global Revenue Market Share of Hyper Immune Globulin by Type (2018-2029)
Figure 58. Global Hyper Immune Globulin Price (US$/Unit) by Type (2018-2029)
Figure 59. Global Sales Market Share of Hyper Immune Globulin by Application (2018-2029)
Figure 60. Global Revenue Market Share of Hyper Immune Globulin by Application (2018-2029)
Figure 61. Global Hyper Immune Globulin Price (US$/Unit) by Application (2018-2029)
Figure 62. Hyper Immune Globulin Value Chain
Figure 63. Hyper Immune Globulin Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Distributors Profiles
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
